Savara Inc Accumulated Other Comprehensive Income
Savara Inc (SVRA) had Accumulated Other Comprehensive Income of -$534.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$534.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$429.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$87.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$155.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$534.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$429.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$87.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | -$155.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$216.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$632.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | -$750.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $299.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$880.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$742.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$271.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$942.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$619.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$461.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$605.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | -$1.61M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$1.02M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$291.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $5.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $285.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $592.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $485.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $942.00K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $252.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $119.00K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$128.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$17.00K 10-K · filed 2021-03-10 | |
| 2019-09-30 | -$236.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $212.00K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $200.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $364.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $456.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.27M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $958.00K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $747.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $404.00K 10-Q · filed 2017-08-09 | |
| 2016-12-31 | -$591.00K 10-K · filed 2018-03-14 | $1.00K 10-K · filed 2017-03-06 |
| 2016-09-30 | $4.00K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $7.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.00K 10-Q · filed 2016-05-06 | |
| 2015-12-31 | -$17.00K 10-K · filed 2017-03-06 | |
| 2015-09-30 | $9.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $9.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | -$2.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$25.00K 10-K · filed 2016-03-14 | |
| 2014-09-30 | -$22.52K 10-Q · filed 2014-10-31 | |
| 2014-06-30 | -$17.91K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$26.18K 10-Q · filed 2014-05-05 | |
| 2013-12-31 | -$21.00K 10-K · filed 2015-03-24 | -$20.74K 10-K · filed 2014-03-26 |
| 2013-09-30 | -$28.72K 10-Q · filed 2013-11-04 | |
| 2013-06-30 | -$8.84K 10-Q · filed 2013-08-05 | |
| 2013-03-31 | -$10.64K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$2.19K 10-K · filed 2014-03-26 | |
| 2012-09-30 | -$2.22K 10-Q · filed 2012-11-05 | |
| 2012-06-30 | -$2.29K 10-Q · filed 2012-08-06 | |
| 2012-03-31 | -$2.16K 10-Q · filed 2012-05-07 | |
| 2011-12-31 | -$2.30K 10-K · filed 2013-03-19 | |
| 2011-09-30 | -$23.10K 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $7.47K 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $0.00 10-Q · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |